Both the FDA and the European Medicines Agency are reviewing deucrictibant for approval.
1 report, 1 independent
Updated Aug 12
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Both the FDA and the European Medicines Agency are reviewing deucrictibant for approval.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- FDA
-
European Medicines Agency
highest regulatory authority on medicines in the European Union
Related events
- Both the FDA and the European Medicines Agency govern drug approval processes.
- The FDA and European Medicines Agency are harmonizing regulatory review of drug applications.
- AbbVie submitted an application for risankizumab approval to the European Medicines Agency.
- OS Therapies, Inc. is seeking interim and final review data submissions from regulatory bodies while attending major global investment conferences.
- Inventiva seeks FDA approval for lanifibranor in the U.S. market.